Found: 67
Select item for more details and to access through your institution.
Self-renewal related signaling in myeloid leukemia stem cells.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Leukemogenic potency of the novel FLT3-N676K mutant.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Diagnosis and treatment of MPN in real life: exploratory and retrospective chart review including 960 MPN patients diagnosed with ET or MF in Germany.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7197, doi. 10.1007/s00432-023-04669-3
- By:
- Publication type:
- Article
Pomalidomide combinations are a safe and effective option after daratumumab failure.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 6569, doi. 10.1007/s00432-023-04637-x
- By:
- Publication type:
- Article
Cytoreductive treatment in real life: a chart review analysis on 1440 patients with polycythemia vera.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 10, p. 2693, doi. 10.1007/s00432-021-03855-5
- By:
- Publication type:
- Article
Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 8, p. 1983, doi. 10.1007/s00432-022-03986-3
- By:
- Publication type:
- Article
Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 5, p. 1481, doi. 10.1007/s00432-020-03430-4
- By:
- Publication type:
- Article
Diverging impact of cell fate determinants Scrib and Llgl1 on adhesion and migration of hematopoietic stem cells.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 10, p. 1933, doi. 10.1007/s00432-018-2724-3
- By:
- Publication type:
- Article
Cell autonomous expression of CXCL-10 in JAK2V617F-mutated MPN.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 5, p. 807, doi. 10.1007/s00432-017-2354-1
- By:
- Publication type:
- Article
Characteristics and treatment of polycythemia vera patients in clinical practice: a multicenter chart review on 1476 individuals in Germany.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 9, p. 2041, doi. 10.1007/s00432-016-2209-1
- By:
- Publication type:
- Article
Taz protects hematopoietic stem cells from an aging-dependent decrease in PU.1 activity.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32970-1
- By:
- Publication type:
- Article
Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00929-8
- By:
- Publication type:
- Article
Leukemic mastopathy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Molecular‐defined clonal evolution in patients with classical myeloproliferative neoplasms.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 308, doi. 10.1111/bjh.18834
- By:
- Publication type:
- Article
Second primary malignancy in myelofibrosis patients treated with ruxolitinib.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 356, doi. 10.1111/bjh.17192
- By:
- Publication type:
- Article
Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 1, p. 35, doi. 10.1111/bjh.15497
- By:
- Publication type:
- Article
Plasma VCAM1 levels correlate with disease severity in Parkinson's disease.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Recurrent Upper Gastrointestinal Bleeding from Isolated Gastric Varices as Primary Symptom of Myelofibrosis: A Case Report on Combining Interventional and Pharmacologic Treatment Options.
- Published in:
- Digestive Diseases, 2022, v. 40, n. 4, p. 530, doi. 10.1159/000518766
- By:
- Publication type:
- Article
Intracellular Retention of ABL Kinase Inhibitors Determines Commitment to Apoptosis in CML Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0040853
- By:
- Publication type:
- Article
MoReLife – real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 10, p. 4065, doi. 10.1007/s00277-024-05908-4
- By:
- Publication type:
- Article
FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN).
- Published in:
- Annals of Hematology, 2024, v. 103, n. 8, p. 2775, doi. 10.1007/s00277-024-05867-w
- By:
- Publication type:
- Article
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 7, p. 2299, doi. 10.1007/s00277-024-05665-4
- By:
- Publication type:
- Article
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 349, doi. 10.1007/s00277-022-05080-7
- By:
- Publication type:
- Article
Rhabdomyolysis induced by nelarabine.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 9, p. 2111, doi. 10.1007/s00277-022-04879-8
- By:
- Publication type:
- Article
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 5, p. 773, doi. 10.1007/s00277-018-3245-5
- By:
- Publication type:
- Article
Prediction of central venous catheter-related bloodstream infections (CRBSIs) in patients with haematologic malignancies using a modified Infection Probability Score (mIPS).
- Published in:
- Annals of Hematology, 2015, v. 94, n. 9, p. 1451, doi. 10.1007/s00277-015-2387-y
- By:
- Publication type:
- Article
3,4-Diarylmaleimides-a novel class of kinase inhibitors-effectively induce apoptosis in FLT3-ITD-dependent cells.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 3, p. 331, doi. 10.1007/s00277-011-1311-3
- By:
- Publication type:
- Article
Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL.
- Published in:
- Oncogene, 2001, v. 20, n. 23, p. 2900, doi. 10.1038/sj.onc.1204401
- By:
- Publication type:
- Article
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09745-2
- By:
- Publication type:
- Article
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3706, doi. 10.3390/cancers15143706
- By:
- Publication type:
- Article
Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4086, doi. 10.3390/cancers13164086
- By:
- Publication type:
- Article
The Role of MacroH2A Histone Variants in Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 3003, doi. 10.3390/cancers13123003
- By:
- Publication type:
- Article
Molecular Mechanisms of Senescence and Implications for the Treatment of Myeloid Malignancies.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 612, doi. 10.3390/cancers13040612
- By:
- Publication type:
- Article
Antiseptic efficacy of two mouth rinses in the oral cavity to identify a suitable rinsing solution in radiation- or chemotherapy induced mucositis.
- Published in:
- BMC Oral Health, 2023, p. 1, doi. 10.1186/s12903-023-02884-5
- By:
- Publication type:
- Article
Severe paraneoplastic pemphigus in a patient with follicular lymphoma.
- Published in:
- 2010
- By:
- Publication type:
- Other
Results of a multicenter phase II trial for older patients with c‐Kit‐positive acute myeloid leukemia (AML) and high‐risk myelodysplastic syndrome (HR‐MDS) using low‐dose Ara‐C and Imatinib.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 5, p. 907, doi. 10.1002/cncr.22471
- By:
- Publication type:
- Article
JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy.
- Published in:
- Nature Communications, 2015, v. 6, n. 3, p. 6496, doi. 10.1038/ncomms7496
- By:
- Publication type:
- Article
Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia Cells.
- Published in:
- Antioxidants, 2022, v. 11, n. 3, p. 513, doi. 10.3390/antiox11030513
- By:
- Publication type:
- Article
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00834-6
- By:
- Publication type:
- Article
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00392-1
- By:
- Publication type:
- Article
Significance of BK Polyomavirus in Long-Term Survivors after Adult Allogeneic Stem Cell Transplantation.
- Published in:
- Biology (2079-7737), 2021, v. 10, n. 6, p. 553, doi. 10.3390/biology10060553
- By:
- Publication type:
- Article
Analysis of anti-proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathways.
- Published in:
- International Journal of Cancer, 2010, v. 127, n. 5, p. 1197, doi. 10.1002/ijc.25137
- By:
- Publication type:
- Article
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 409, doi. 10.1002/hon.2843
- By:
- Publication type:
- Article
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article